(Post-pandemic Era)-Global The Betahistine Market Segment Research Report 2023

Report ID: 874361 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global The Betahistine Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The Betahistine Market by Value
      2.2.1 Global The Betahistine Revenue by Type
      2.2.2 Global The Betahistine Market by Value (%)
    2.3 Global The Betahistine Market by Production
      2.3.1 Global The Betahistine Production by Type
      2.3.2 Global The Betahistine Market by Production (%)

3. The Major Driver of The Betahistine Industry
    3.1 Historical & Forecast Global The Betahistine Demand
    3.2 Largest Application for The Betahistine (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Betahistine Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The Betahistine Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The Betahistine Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Betahistine Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Betahistine Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Betahistine Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Betahistine Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Betahistine Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Betahistine Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Betahistine Average Price Trend
    12.1 Market Price for Each Type of The Betahistine in US (2017-2021)
    12.2 Market Price for Each Type of The Betahistine in Europe (2017-2021)
    12.3 Market Price for Each Type of The Betahistine in China (2017-2021)
    12.4 Market Price for Each Type of The Betahistine in Japan (2017-2021)
    12.5 Market Price for Each Type of The Betahistine in India (2017-2021)
    12.6 Market Price for Each Type of The Betahistine in Korea (2017-2021)
    12.7 Market Price for Each Type of The Betahistine in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The Betahistine Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The Betahistine

14. The Betahistine Competitive Landscape
     14.1 TOWA PHARMACEUTICAL CO., LTD
        14.1.1 TOWA PHARMACEUTICAL CO., LTD Company Profiles
        14.1.2 TOWA PHARMACEUTICAL CO., LTD Product Introduction
        14.1.3 TOWA PHARMACEUTICAL CO., LTD The Betahistine Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 Ciclum Farma Unipessoal
        14.2.1 Ciclum Farma Unipessoal Company Profiles
        14.2.2 Ciclum Farma Unipessoal Product Introduction
        14.2.3 Ciclum Farma Unipessoal The Betahistine Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 EA Pharma Co., Ltd.
        14.3.1 EA Pharma Co., Ltd. Company Profiles
        14.3.2 EA Pharma Co., Ltd. Product Introduction
        14.3.3 EA Pharma Co., Ltd. The Betahistine Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 Nichi-Iko Pharmaceutical
        14.4.1 Nichi-Iko Pharmaceutical Company Profiles
        14.4.2 Nichi-Iko Pharmaceutical Product Introduction
        14.4.3 Nichi-Iko Pharmaceutical The Betahistine Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 DOC Generici
        14.5.1 DOC Generici Company Profiles
        14.5.2 DOC Generici Product Introduction
        14.5.3 DOC Generici The Betahistine Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
     14.6 Takeda Pharmaceutical Company Limited
        14.6.1 Takeda Pharmaceutical Company Limited Company Profiles
        14.6.2 Takeda Pharmaceutical Company Limited Product Introduction
        14.6.3 Takeda Pharmaceutical Company Limited The Betahistine Sales, Revenue (2017-2021)
        14.6.4 Strategic initiatives
     14.7 Orion Corporation
        14.7.1 Orion Corporation Company Profiles
        14.7.2 Orion Corporation Product Introduction
        14.7.3 Orion Corporation The Betahistine Sales, Revenue (2017-2021)
        14.7.4 Strategic initiatives
     14.8 HENNIG ARZNEIMITTEL GmbH & Co. KG
        14.8.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Company Profiles
        14.8.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Product Introduction
        14.8.3 HENNIG ARZNEIMITTEL GmbH & Co. KG The Betahistine Sales, Revenue (2017-2021)
        14.8.4 Strategic initiatives
     14.9 Disphar International B.V.
        14.9.1 Disphar International B.V. Company Profiles
        14.9.2 Disphar International B.V. Product Introduction
        14.9.3 Disphar International B.V. The Betahistine Sales, Revenue (2017-2021)
        14.9.4 Strategic initiatives
     14.10 Mylan
        14.10.1 Mylan Company Profiles
        14.10.2 Mylan Product Introduction
        14.10.3 Mylan The Betahistine Sales, Revenue (2017-2021)
        14.10.4 Strategic initiatives
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The Betahistine Industry (Volume)
    Figure 2. The Betahistine Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The Betahistine Revenue in 2021
    Figure 5. US The Betahistine Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The Betahistine Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The Betahistine Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The Betahistine Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The Betahistine Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The Betahistine Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The Betahistine Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The Betahistine Revenue, by Type (Million USD) (2017-2027)
    Table 4. The Betahistine Production, by Type (K Unit) (2017-2027)
    Table 5. The Betahistine Demand (K Unit) by Application (2017-2027)
    Table 6. The Betahistine Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The Betahistine Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The Betahistine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The Betahistine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The Betahistine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The Betahistine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The Betahistine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The Betahistine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The Betahistine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The Betahistine in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The Betahistine in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The Betahistine in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The Betahistine in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The Betahistine in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The Betahistine in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The Betahistine in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. TOWA PHARMACEUTICAL CO., LTD Profiles
    Table 61. TOWA PHARMACEUTICAL CO., LTD The Betahistine Product Introduction
    Table 62. TOWA PHARMACEUTICAL CO., LTD The Betahistine Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. TOWA PHARMACEUTICAL CO., LTD Strategic initiatives
    Table 64. Ciclum Farma Unipessoal Profiles
    Table 65. Ciclum Farma Unipessoal The Betahistine Product Introduction
    Table 66. Ciclum Farma Unipessoal The Betahistine Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. Ciclum Farma Unipessoal Strategic initiatives
    Table 68. EA Pharma Co., Ltd. Profiles
    Table 69. EA Pharma Co., Ltd. The Betahistine Product Introduction
    Table 70. EA Pharma Co., Ltd. The Betahistine Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. EA Pharma Co., Ltd. Strategic initiatives
    Table 72. Nichi-Iko Pharmaceutical Profiles
    Table 73. Nichi-Iko Pharmaceutical The Betahistine Product Introduction
    Table 74. Nichi-Iko Pharmaceutical The Betahistine Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. Nichi-Iko Pharmaceutical Strategic initiatives
    Table 76. DOC Generici Profiles
    Table 77. DOC Generici The Betahistine Product Introduction
    Table 78. DOC Generici The Betahistine Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 79. DOC Generici Strategic initiatives
    Table 80. Takeda Pharmaceutical Company Limited Profiles
    Table 81. Takeda Pharmaceutical Company Limited The Betahistine Product Introduction
    Table 82. Takeda Pharmaceutical Company Limited The Betahistine Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 83. Takeda Pharmaceutical Company Limited Strategic initiatives
    Table 84. Orion Corporation Profiles
    Table 85. Orion Corporation The Betahistine Product Introduction
    Table 86. Orion Corporation The Betahistine Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 87. Orion Corporation Strategic initiatives
    Table 88. HENNIG ARZNEIMITTEL GmbH & Co. KG Profiles
    Table 89. HENNIG ARZNEIMITTEL GmbH & Co. KG The Betahistine Product Introduction
    Table 90. HENNIG ARZNEIMITTEL GmbH & Co. KG The Betahistine Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 91. HENNIG ARZNEIMITTEL GmbH & Co. KG Strategic initiatives
    Table 92. Disphar International B.V. Profiles
    Table 93. Disphar International B.V. The Betahistine Product Introduction
    Table 94. Disphar International B.V. The Betahistine Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 95. Disphar International B.V. Strategic initiatives
    Table 97. Mylan Profiles
    Table 98. Mylan The Betahistine Product Introduction
    Table 99. Mylan The Betahistine Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The Betahistine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The Betahistine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The Betahistine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports